Over 1750 Total Lots Up For Auction at Five Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08

Spanish Spanish

Global pediatric proton therapy market predicted to be worth over $700 million by 2021

Press releases may be edited for formatting or style | September 11, 2017 Rad Oncology Pediatrics Proton Therapy
Share
Proton Therapy - Driving Factors
Proton Therapy - Challenges
Global Proton Therapy - Company Analysis (2010-2021)
Proton Therapy - Reimbursement Policies

Companies Mentioned

Hitachi
IBA
Mitsubishi
Varian Medical Systems
For more information about this report visit https://www.researchandmarkets.com/research/vwd572/global_pediatric

SOURCE Research and Markets

Back to HCB News
Sign up for Rad Oncology stories Sign up for Weekly Top stories

You Must Be Logged In To Post A Comment

Sign up for Weekly Top stories

Sign up for Rad Oncology stories

 

advertisement

Rad Oncology Homepage

Accuray showcases advances in radiation therapy solutions at ESTRO 2024
Raigmore Hospital in Scotland selects RayCare
GT Medical Technologies completes strategic acquisition of radioactive seed assets from Perspective Therapeutics, Inc.
World leading carbon ion center QST in Japan selects RayStation
NAPT Honors Proton Therapy Caregivers, Advocates with First Annual Excellence Awards
Oklahoma Proton Center celebrates milestone achievement: 5,000th patient successfully treated
Two clinical studies show high-risk and recurrent prostate cancers can be treated in five days with Accuray CyberKnife
RefleXion and Limbus AI announce technology integration to expedite cancer treatment planning
C-RAD receives an order of 12 MSEK from Italy, related to an extension of the national Consip tender
Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients